Lee C
Asian J Pharm Sci. 2023; 18(5):100853.
PMID: 37908235
PMC: 10613916.
DOI: 10.1016/j.ajps.2023.100853.
Tsume Y, Ashworth L, Bermejo M, Cheng J, Cicale V, Dressman J
AAPS J. 2023; 25(3):45.
PMID: 37085637
DOI: 10.1208/s12248-023-00793-7.
Sakamoto A, Sugano K
Pharm Res. 2023; 40(4):989-998.
PMID: 37024757
DOI: 10.1007/s11095-023-03508-x.
Pepin X, Hammarberg M, Mattinson A, Moir A
Pharm Res. 2022; 40(2):387-403.
PMID: 36002614
DOI: 10.1007/s11095-022-03339-2.
Martinez M, Wu F, Sinko B, Brayden D, Grass M, Kesisoglou F
AAPS J. 2022; 24(3):61.
PMID: 35501528
DOI: 10.1208/s12248-022-00713-1.
Lost in modelling and simulation?.
Sugano K
ADMET DMPK. 2022; 9(2):75-109.
PMID: 35299768
PMC: 8920108.
DOI: 10.5599/admet.923.
In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications.
Garcia M, Varum F, Al-Gousous J, Hofmann M, Page S, Langguth P
Pharmaceutics. 2022; 14(2).
PMID: 35214024
PMC: 8876830.
DOI: 10.3390/pharmaceutics14020291.
Understanding the local chemical environment of bioelectrocatalysis.
Edwardes Moore E, Cobb S, Margarida Coito A, Oliveira A, Pereira I, Reisner E
Proc Natl Acad Sci U S A. 2022; 119(4).
PMID: 35058361
PMC: 8795565.
DOI: 10.1073/pnas.2114097119.
Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) Drugs.
Li M, Zhang X, Wu D, Anand O, Chen H, Raines K
AAPS J. 2021; 23(6):113.
PMID: 34704158
DOI: 10.1208/s12248-021-00639-0.
Label-Free, Real-Time Measurement of Metabolism of Adherent and Suspended Single Cells by In-Cell Fourier Transform Infrared Microspectroscopy.
Vannocci T, Quaroni L, De Riso A, Milordini G, Wolna M, Cinque G
Int J Mol Sci. 2021; 22(19).
PMID: 34639083
PMC: 8509135.
DOI: 10.3390/ijms221910742.
Capture and displacement-based release of the bicarbonate anion by calix[4]pyrroles with small rigid straps.
Heo N, Yang J, Lynch V, Ko B, Sessler J, Kuk Kim S
Chem Sci. 2021; 11(31):8288-8294.
PMID: 34094182
PMC: 8163245.
DOI: 10.1039/d0sc03445b.
Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems.
Blechar J, Al-Gousous J, Wilhelmy C, Postina A, Getto M, Langguth P
Pharmaceutics. 2020; 12(12).
PMID: 33321933
PMC: 7764239.
DOI: 10.3390/pharmaceutics12121197.
Biphasic Dissolution as an Exploratory Method During Early Drug Product Development.
Silva D, Al-Gousous J, Davies N, Chacra N, Webster G, Lipka E
Pharmaceutics. 2020; 12(5).
PMID: 32370237
PMC: 7284338.
DOI: 10.3390/pharmaceutics12050420.
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP.
Bermejo M, Hens B, Dickens J, Mudie D, Paixao P, Tsume Y
Pharmaceutics. 2020; 12(1).
PMID: 31963448
PMC: 7023481.
DOI: 10.3390/pharmaceutics12010074.
Mechanisms of Small Heat Shock Proteins.
Janowska M, Baughman H, Woods C, Klevit R
Cold Spring Harb Perspect Biol. 2019; 11(10).
PMID: 30833458
PMC: 6771367.
DOI: 10.1101/cshperspect.a034025.
Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State.
Paixao P, Bermejo M, Hens B, Tsume Y, Dickens J, Shedden K
Mol Pharm. 2018; 15(12):5468-5478.
PMID: 30417648
PMC: 8859981.
DOI: 10.1021/acs.molpharmaceut.8b00736.
Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.
Bermejo M, Paixao P, Hens B, Tsume Y, Koenigsknecht M, Baker J
Mol Pharm. 2018; 15(12):5454-5467.
PMID: 30372084
PMC: 8851507.
DOI: 10.1021/acs.molpharmaceut.8b00515.
In Vivo Predictive Dissolution and Simulation Workshop Report: Facilitating the Development of Oral Drug Formulation and the Prediction of Oral Bioperformance.
Tsume Y, Patel S, Fotaki N, Bergstrm C, Amidon G, Brasseur J
AAPS J. 2018; 20(6):100.
PMID: 30191341
PMC: 8830932.
DOI: 10.1208/s12248-018-0260-3.
Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.
Hens B, Sinko P, Job N, Dean M, Al-Gousous J, Salehi N
Int J Pharm. 2018; 548(1):120-127.
PMID: 29944899
PMC: 8845961.
DOI: 10.1016/j.ijpharm.2018.06.050.
Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.
Hens B, Talattof A, Paixao P, Bermejo M, Tsume Y, Lobenberg R
AAPS J. 2018; 20(3):57.
PMID: 29600330
DOI: 10.1208/s12248-018-0217-6.